Real-time enrollment status for this solid tumor, adult clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 6:26 PM UTC
| NCT Number | NCT04913285 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor, Adult |
| Phase | PHASE1 |
| Target Enrollment | 400 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Pierre Fabre Medicament |
| Last Updated on CT.gov | September 2, 2026 (18 hours ago) |
As of September 2, 2026: Clinical trial NCT04913285 is currently recruiting participants. This phase1 study for solid tumor, adult is actively seeking new participants at 15 locations across the United States. The study is sponsored by Pierre Fabre Medicament. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04913285 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04913285 was last updated 18 hours ago (September 2, 2026). HelloStudys verifies this status automatically.